EHealth Technologies in Inflammatory Bowel Disease: A Systematic Review
Belinda D Jackson1, Kathleen Gray2, Simon R Knowles3
1Department of Gastroenterology, The Austin Hospital, Melbourne Australia Department of Medicine, University of Melbourne, Austin Academic Centre, Melbourne, Australia.
Electronic-health (eHealth) technologies improve inflammatory bowel disease (IBD) management by enhancing self-care and reducing healthcare costs. These digital tools show potential for better patient outcomes and efficient resource use in IBD patient care.
Area of Science:
- Gastroenterology
- Digital Health
- Health Services Research
Background:
- Electronic-health (eHealth) technologies are increasingly utilized for managing inflammatory bowel disease (IBD).
- These technologies include web-based interventions, virtual clinics, smartphone applications, and telemedicine.
- Their role in IBD patient management is expanding.
Purpose of the Study:
- To evaluate the impact of eHealth on clinical indices and patient-reported outcomes (PROs) in IBD.
- To assess the effectiveness, cost-effectiveness, and feasibility of eHealth for IBD self-management.
- To provide recommendations for eHealth design and implementation in IBD care.
Main Methods:
- A literature search identified 17 relevant publications.
- Included studies comprised six randomized controlled trials and nine observational studies.
- Publications were selected based on predefined quality parameters.
Main Results:
- eHealth technologies improved relapse duration, disease activity, medication adherence, and quality of life in IBD patients.
- Studies indicated reduced healthcare costs and fewer acute visits for IBD symptoms.
- eHealth facilitated remote management for a significant portion of IBD cohorts.
Conclusions:
- eHealth technologies hold significant potential for promoting self-management in IBD.
- These tools can help reduce the burden of IBD on healthcare resource utilization.
- A theoretical framework is recommended for developing, implementing, and evaluating eHealth interventions for IBD.
More Related Videos
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
09:01Non-invasive Assessment of the Efficacy of New Therapeutics for Intestinal Pathologies Using Serial Endoscopic Imaging of Live Mice
Published on: March 10, 2015
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
